F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 74,984 shares at $22.36 ($1.7M) on 2022-09-27, disclosed to the SEC on 2022-09-29.
Open-market sale of $1.7M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.36 | 14,424 | $323K | 18.9% |
| 2 | $22.36 | 14,424 | $323K | 18.9% |
| 3 | $23.03 | 23,068 | $531K | 31.1% |
| 4 | $23.03 | 23,068 | $531K | 31.1% |
| Total | $22.77 avg | 74,984 | $1.7M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |